For many people with pancreatic cancer, surgery is not an option at the time of diagnosis. But that doesn’t mean treatment stops—it means the treatment strategy changes.
Today, there is a modern, multidisciplinary treatment that focuses on prolonging survival, alleviating symptoms, and maintaining quality of life.
The treatment is adjusted over time
Pancreatic cancer that cannot be treated surgically is often treated with several consecutive lines of therapy, during which doctors continuously evaluate the effectiveness and adjust the treatment based on the disease’s progression and the patient’s overall condition.
The most important message is that treatment does not end when surgery is not an option—it evolves and is adapted.
Important treatment options include:
- Systemic chemotherapy – forms the basis of treatment and can improve both survival and disease control.
- Chemoradiotherapy – can be used in selected cases without metastases to control the tumor locally.
- Targeted therapy – applicable to a smaller group of patients with specific genetic alterations in the tumor.
- Immunotherapy – may be effective for rare subgroups, such as tumors with high microsatellite instability (MSI-high).
- Palliative care – a central part of treatment, involving active symptom relief and support to maintain the best possible quality of life.
- Clinical trials– provide access to new and promising treatment methods currently under development.
Summary
Even when surgery is not an option, there are good opportunities to slow the disease, relieve symptoms, and improve quality of life through a personalized combination of different treatment methods.
